Mark Vajaranant
Impact in
- Infectious Diseases top 5%
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
- Emergency Medicine top 5%
- HIV-related health complications and treatments
Papers in
-
- HIV/AIDS Research and Interventions 6
- HIV/AIDS drug development and treatment 1
-
- Maternal and fetal healthcare 2
- Global Maternal and Child Health 2
- Co-authors
- Carmen Zorrilla (6 shared papers)Ruth Tuomala (6 shared papers)Bruce Thompson (4 shared papers)Sheldon H. Landesman (3 shared papers)Hunter Hammill (3 shared papers)D. Heather Watts (2 shared papers)Daner Li (2 shared papers)Jane Pitt (1 shared paper)
- Journals
- JAIDS Journal of Acquired Immune Deficiency Syndromes (7 papers)Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology (1 paper)
- Partner nations
- Puerto RicoUnited StatesHungary
In The Last Decade
Mark Vajaranant
8 papers receiving 354 citations
Peers
Comparison fields: 5 of 27
- Infectious Diseases 242
- Emergency Medicine 77
- Virology 36
- Epidemiology 68
- Obstetrics and Gynecology 13
Countries citing papers authored by Mark Vajaranant
This map shows the geographic impact of Mark Vajaranant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Vajaranant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Vajaranant more than expected).
Fields of papers citing papers by Mark Vajaranant
This network shows the impact of papers produced by Mark Vajaranant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Vajaranant. The network helps show where Mark Vajaranant may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Vajaranant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 129 | |
| 2 | 2001 | 57 | |
| 3 | 2000 | 50 | |
| 4 | 2001 | 42 | |
| 5 | 2006 | 41 | |
| 6 | 2000 | 29 | |
| 7 | 2006 | 17 | |
| 8 | 1999 | 3 |
About Mark Vajaranant
Mark Vajaranant is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health, Epidemiology, Emergency Medicine and Organic Chemistry, having authored 8 papers that have together received 368 indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (6 papers), Maternal and fetal healthcare (2 papers), Global Maternal and Child Health (2 papers), HIV-related health complications and treatments (2 papers), HIV/AIDS drug development and treatment (1 paper), HIV, Drug Use, Sexual Risk (1 paper) and Cervical Cancer and HPV Research (1 paper). The work is most often cited by research in Infectious Diseases (242 citations), Emergency Medicine (77 citations), Virology (36 citations), Epidemiology (68 citations) and Obstetrics and Gynecology (13 citations). Mark Vajaranant has collaborated with scholars based in Puerto Rico, United States and Hungary. Frequent co-authors include Carmen Zorrilla, Ruth Tuomala, Bruce Thompson, Sheldon H. Landesman, Hunter Hammill, D. Heather Watts, Daner Li, Jane Pitt, Jennifer S. Read and Eloi Kpamegan. Their work appears in journals such as JAIDS Journal of Acquired Immune Deficiency Syndromes and Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.